Δευτέρα 19 Φεβρουαρίου 2018

OxyContin maker stops marketing opioids, as report details payments to advocacy groups

Purdue Pharma, targeted in over 200 lawsuits for its role in the US opioid epidemic with fraudulent marketing of its semi-synthetic pill OxyContin, has cut its sales staff by half and said it would...
recent?d=yIl2AUoC8zA recent?d=dnMXMwOfBR0 recent?i=wGfwioOVf4Y:8JB4M4n0S6Q:V_sGLiP recent?d=qj6IDK7rITs recent?i=wGfwioOVf4Y:8JB4M4n0S6Q:gIN9vFw recent?d=l6gmwiTKsz0 recent?d=7Q72WNTAKBA recent?i=wGfwioOVf4Y:8JB4M4n0S6Q:F7zBnMy recent?i=wGfwioOVf4Y:8JB4M4n0S6Q:-BTjWOF


from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2CyvzZe
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις